๐Ÿ“–
CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids.
Ren ZR, Wu L, Huang QL, Cai DX, Peng YL, Tang LB, Li JT, Zhu HY, Xu CR, Lu C, Chen ZH, Deng Y, Lin YJ, Zhou Q

CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Glob Med Genet.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids.
Author / Organization Ren ZR, Wu L, Huang QL, Cai DX, Peng YL, Tang LB, Li JT, Zhu HY, Xu CR, Lu C, Chen ZH, Deng Y, Lin YJ, Zhou Q
Subject & Discipline Glob Med Genet
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-8276
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »